A 55-year-old woman developed painful, red facial and neck lesions with fever two days after starting inhaled indacaterol/glycopyrronium for COPD. Blood tests showed neutrophilia; biopsy confirmed Sweet syndrome.
Lesions improved with corticosteroids after stopping the drug. This is the first reported case linked to inhaled therapy, highlighting the need for primary care awareness of rare drug reactions and the importance of ruling out systemic disease.
In a heartbreaking incident that has left a community in shock, a 5-month-old baby was critically injured after being struck by a stray bullet. The tragedy has…
Your little finger might appear to be the smallest and least significant part of your hand, yet throughout history, people have linked it to meaning, symbolism, and…
For years, hosting Christmas felt less like a choice and more like an expectation. My home was the largest, so it automatically became the gathering place. Every…
A powerful 8.2 magnitude earthquake struck the Alaskan Peninsula late Wednesday, triggering tsunami warnings and intense monitoring across the Pacific region. The quake occurred at a depth…
Nearly 100 Minnesota Mayors Warn State Fiscal Policies Are Straining Cities Nearly 100 Minnesota mayors have united to send a formal letter to Governor Tim Walz and state…
A father walked into his Chicago home and straight into hell. Six loved ones, including two children, lay lifeless in what police called a “sea of blood.”…
